Intellia Therapeutics NTLA Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Intellia Therapeutics's total liabilities?
- Intellia Therapeutics (NTLA) reported total liabilities of $137.84M in Q1 2026.
- How has Intellia Therapeutics's total liabilities changed year-over-year?
- Intellia Therapeutics's total liabilities decreased by 33.2% year-over-year, from $206.24M to $137.84M.
- What is the long-term trend for Intellia Therapeutics's total liabilities?
- Over 3 years (2022 to 2025), Intellia Therapeutics's total liabilities has grown at a -15.7% compound annual growth rate (CAGR), from $284.53M to $170.73M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.